Program Overview:
The joint providership of Medical Education Resources and Focus Medical Communications presents the 29th Annual IU GI & Hepatology Update. This educational activity will provide an educational update focused on new developments in gastroenterology and hepatology, specifically "breakthrough" research with clinical relevance.
Target Audience:
This activity has been designed to meet the educational needs of physicians, physician assistants/associates, and nurse practitioners involved in the care of patients with chronic liver disease (CLD) and gastrointestinal (GI) disorders.
Educational Objectives:
After completing this activity, the participant should be better able to:
-
Describe current screening, diagnosis, and management options for patients with CLD and GI disorders
-
Apply optimal treatment strategies for patients with CLD and GI disorders
-
Compare and contrast currently available treatment modalities for CLD and GI disorders
Accreditation Statement:
In support of improving patient care, this activity has been planned and implemented by Medical Education Resources (MER) and Focus Medical Communications. MER is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Credit:
Medical Education Resources designates this live activity for a maximum of 10.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse Credit:
Medical Education Resources designates this live activity for a maximum of 10.0 ANCC nursing contact hour(s). Nurses will be awarded contact hours upon successful completion of the activity. This activity is designated for ANCC pharmacotherapeutic contact hour(s).
MOC Designation:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 10.0 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Disclosures:
-
Planning Committee:
-
Mohammad Al-Haddad, MD, MSc, FASGE, FACG, AGAF
-
Consultant: Boston Scientific, Olympus
-
Research Support: Amplified Sciences
-
-
Mark A. Gromski, MD, FASGE
-
Consultant: Boston Scientific, Cook Medical
-
Scientific Advisory Board: Cook Medical
-
Clinical Advisory Board: Fractyl
-
Research Support: Fractyl, Allurion
-
-
Brett J. Hoskins, DO
-
Consultant: Mirum Pharmaceuticals, 3-D Matrix, Medtronic
-
Research Support: Mirum Pharmaceuticals, Medtronic, Travere Therapeutics, Albireo/Ipsen Pharmaceuticals
-
-
Douglas K. Rex, MD, MACP, MACG, MASGE, AGAF
-
Consultant: Boston Scientific, Olympus, Medtronic, Braintree Laboratories, Laborie, Sebela Pharmaceuticals
-
Research Support: Boston Scientific, Olympus, Medtronic, Sebela Pharmaceuticals, Erbe
-
-
Sarah A. Stainko, MSN, FNP-C
-
I have no relationships to disclose.
-
-
-
>> Faculty speaker disclosures are listed in the presentations.
Disclosure of Relevant Financial Relationships:
Medical Education Resources (MER) ensures balance, independence, objectivity, and scientific rigor in all our educational activities. In accordance with this policy, MER identifies all financial relationships with its instructors, content managers, and other individuals who are in a position to control the content of an activity. Reported relevant financial relationships are mitigated by MER to ensure that all scientific research referred to, reported, or used in a CE activity conforms to the generally accepted standards of experimental design, data collection, and analysis. MER is committed to providing learners with high-quality CE activities that promote improvements or quality in health care and not the business interest of an ineligible company.
MER and Focus Medical Communications planners have no relevant financial relationships to disclose.
Disclaimer:
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of Medical Education Resources and/or Focus Medical Communications. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
Fee Information:
https://www.iugiupdate.org/pricing
Special requests: AMERICANS WITH DISABILITIES ACT: The event staff will be glad to assist you with any special needs (i.e., physical, dietary). Please contact us prior to the event at iugiupdate@focusmeded.com.
